Clinical Trial Update: Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to Lamivudine [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Tenofovir Disoproxil Fumarate alone versus Emtricitabine/Tenofovir DF in lamivudine-resistant hepatitis B; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)
• Viread (Tenofovir disoproxil fumarate) (Tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2013-04-11